|Bid||6.88 x 1200|
|Ask||7.49 x 800|
|Day's range||6.82 - 7.20|
|52-week range||5.61 - 17.46|
|Beta (3Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||6 Nov 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||21.60|
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Investing in stocks comes with the risk that the share price will fall. Unfortunately, shareholders of Unity...
The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology